Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT06418308

Intrathecal Dexmedetomidine vs Epinephrine

Conditions: Cesarean Section, Anesthesia, Spinal

Sex: Female
Ages: 18 Years – 55 Years
Healthy volunteers: No
Phase: PHASE4
Enrollment: 90
Sponsor: Icahn School of Medicine at Mount Sinai

Location: Mount Sinai Hospital New York New York

Summary

Several studies have shown that adding dexmedetomidine or epinephrine to single-dose spinal analgesia preparations improves the length and/or speed of onset of the sensory block and post-operative pain management without increased negative side effects. To date, however, no study has compared adjunctive intrathecal dexmedetomidine to adjunctive intrathecal epinephrine in single-dose spinal analgesia. The purpose of this study is to determine if adjunctive intrathecal dexmedetomidine is non-inferior to adjunctive intrathecal epinephrine in providing better single-dose spinal analgesia during cesarean section.

Eligibility Criteria

Inclusion Criteria: * Pregnant patients * aged 18-55 years * presenting for scheduled primary or secondary cesarean section * candidates for single shot spinal anesthesia singleton pregnancy Exclusion Criteria: * patient refusal of spinal anesthetic * if patient is not a candidate for spinal anesthesia due to history of coagulopathy, elevated intracranial pressure, infection at site of injection, etc. * emergency cesarean section * preexisting motor or sensory deficit * suspected pre-eclampsia * patient receiving combined spinal-epidural as anesthetic technique * BMI \> 40

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06418308). StuddyBuddy aggregates publicly available trial information.